TARDBP is a human gene whose product nRBP1 (Nuclear Receptor Binding Protein 1) is a conserved eukaryotic protein that functions as a transcriptional co-regulator and scaffold protein. It interacts with nuclear receptors and various signaling pathways to modulate gene expression. Variants in TARDBP have been implicated in Alzheimer's Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration. [1]
NRBP1 (Nuclear Receptor Binding Protein 1) is a conserved eukaryotic protein that functions as a transcriptional co-regulator and scaffold protein. It interacts with nuclear receptors and various signaling pathways to modulate gene expression.
Transcriptional Regulation: NRBP1 acts as a co-activator for nuclear receptors including glucocorticoid receptor, estrogen receptor, and thyroid hormone receptor. It facilitates recruitment of transcriptional machinery to target gene promoters.
Cell Signaling Hub: NRBP1 integrates signals from multiple pathways including NF-κB, WNT, and MAPK cascades. It modulates downstream transcriptional outputs in response to cellular stress.
Cell Cycle Regulation: The protein participates in cell cycle control through interactions with cyclin-dependent kinases and cell cycle regulators. Dysregulation can lead to abnormal proliferation or cell death.
Mitochondrial Function: NRBP1 localizes to mitochondria under stress conditions and influences mitochondrial dynamics, apoptosis, and cellular energy metabolism.
NRBP1 is implicated in AD through its role in tau protein phosphorylation and amyloid processing. Studies show altered NRBP1 expression in AD brain tissue, particularly in regions vulnerable to neurodegeneration. The protein interacts with GSK3β, a key kinase in tau hyperphosphorylation.
In PD, NRBP1 participates in α-synuclein-induced toxicity pathways. It may modulate ER stress responses and protein aggregation mechanisms that are central to PD pathogenesis.
NRBP1 expression is altered in ALS motor neurons. The protein interacts with TDP-43 (encoded by TARDBP and FUS protein pathways. Dysregulation may contribute to RNA metabolism defects observed in ALS.
NRBP1 is ubiquitously expressed but shows highest levels in:
In the brain, NRBP1 is expressed in:
Expression is upregulated by cellular stress, oxidative stress, and inflammatory signals.
NRBP1's role as a transcriptional co-regulator makes it an attractive target for:
NRBP1 levels in cerebrospinal fluid (CSF) have been investigated as a potential biomarker for neurodegenerative diseases. Changes in NRBP1 may reflect neuronal injury or dysfunction.
Yamamoto et al. NRBP1 and ER stress in PD models (2021). 2021. ↩︎